Results 171 to 180 of about 9,669,605 (361)

Mineral resources in life cycle impact assessment—part I: a critical review of existing methods

open access: yesThe International Journal of Life Cycle Assessment, 2020
T. Sonderegger   +19 more
semanticscholar   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

The life cycle of star clusters in a tidal field [PDF]

open access: green, 2011
Mark Gieles   +2 more
openalex   +1 more source

Techno-economic life cycle assessment of CO2-EOR operations towards net negative emissions at farnsworth field unit

open access: green, 2023
Anthony Morgan   +5 more
openalex   +2 more sources

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

open access: yesMolecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He   +8 more
wiley   +1 more source

Hepatitis B virus biology and life cycle.

open access: yesAntiviral Research, 2020
Senko Tsukuda, Koichi Watashi
semanticscholar   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Thiamine Allocation and Deficiency Status Throughout the Life Cycle of Cod. [PDF]

open access: yesEcol Evol
Hauber MM   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy